Literature DB >> 12410345

History and prospects for viral disease eradication.

Ciro A de Quadros1.   

Abstract

Edward Jenner first articulated the concept of eradication when he first inoculated the vaccinia. Before considering a disease for eradication some factors should be considered, such as the biological characteristics of the infectious agent: does the infectious agent infects only humans? Does it have a non-human reservoir and induce long-life immunity after infection? Is there a tool or intervention that effectively interrupts the chain of transmission from one individual to another? The first disease to be eradicated was smallpox. This extraordinary initiative set the example for any future disease eradication program. The eradication of polio from the Americas was launched in May 1985 and the Region of the Americas was certified polio-free in September 1994. At this same year, the Pan American Health Organization (PAHO) launched an initiative to eradicate measles from the Americas. Only 1,500 cases have been reported during the year 2000, and transmission was interrupted in most countries of the Region. Tremendous progress has been achieved in disease eradication efforts, which resulted in the global eradication of smallpox, the eradication of poliomyelitis from the Americas and its nearly global eradication, and the nearly complete eradication of measles from the Americas. The biotechnology revolution is providing us with many new vaccines and we have to continue the search for those diseases that could eventually be eradicated. Eradication of a disease brings the greatest health benefit, which is the absence of the health threat. It is also the quintessential example of health equity, as all mankind reaps the benefits, bringing eternal cost savings. As Louis Pasteur pointed out, "it is within the power of man to eradicate infection from the earth".

Entities:  

Mesh:

Year:  2002        PMID: 12410345     DOI: 10.1007/s00430-002-0120-7

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  6 in total

1.  Global drivers of human pathogen richness and prevalence.

Authors:  Robert R Dunn; T Jonathan Davies; Nyeema C Harris; Michael C Gavin
Journal:  Proc Biol Sci       Date:  2010-04-14       Impact factor: 5.349

2.  Protective capacity of memory CD8+ T cells is dictated by antigen exposure history and nature of the infection.

Authors:  Jeffrey C Nolz; John T Harty
Journal:  Immunity       Date:  2011-05-05       Impact factor: 31.745

3.  Community perceptions of a malaria vaccine in the Kintampo districts of Ghana.

Authors:  Lawrence G Febir; Kwaku P Asante; Dan-Bright S Dzorgbo; Kojo A Senah; Timothy S Letsa; Seth Owusu-Agyei
Journal:  Malar J       Date:  2013-05-07       Impact factor: 2.979

4.  Following in the footsteps of smallpox: can we achieve the global eradication of measles?

Authors:  Oliver WC Morgan
Journal:  BMC Int Health Hum Rights       Date:  2004-03-17

5.  Stakeholders' opinions and questions regarding the anticipated malaria vaccine in Tanzania.

Authors:  Sally Mtenga; Angela Kimweri; Idda Romore; Ali Ali; Amon Exavery; Elisa Sicuri; Marcel Tanner; Salim Abdulla; John Lusingu; Shubi Kafuruki
Journal:  Malar J       Date:  2016-04-05       Impact factor: 2.979

6.  Political epidemiology: strengthening socio-political analysis for mass immunisation - lessons from the smallpox and polio programmes.

Authors:  S Taylor
Journal:  Glob Public Health       Date:  2009
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.